Name | H-p-Chloro-Phe-D-Cys-β-(3-pyridyl)-Ala-D-Trp-N-Me-Lys-Thr-Cys-2-Nal-NH2 |
---|---|
Synonyms | H-p-Chloro-Phe-D-Cys-b-(3-pyridyl)-Ala-D-Trp-N-Me-Lys-Thr-Cys-2-Nal-NH2 |
Description | PRL 3195 is a somatostatin receptor antagonist with Kis of 6, 17, 66, 1000 and 1000 nM for human somatostatin receptors (sst5, sst2, sst3, sst1 and sst4, respectively)[1]. |
---|---|
Related Catalog | |
Target |
hsst5:6 nM (Ki) hsst2:17 nM (Ki) hsst3:66 nM (Ki) hsst1:1000 nM (Ki) hsst4:1000 nM (Ki) rat urotensin II receptor:429 nM (Ki) human urotensin II receptor:1846 nM (Ki) |
In Vitro | PRL 3195 抑制人尿紧素 II (human urotensin II) 诱导的大鼠主动脉相位振荡,ED50 为 24 nM[1]。 |
References |
Molecular Formula | C58H71ClN12O9S2 |
---|---|
Molecular Weight | 1179.84000 |
Exact Mass | 1178.46000 |
PSA | 416.55000 |
LogP | 6.00420 |